Related Experiment Video
Updated: Jan 29, 2026

Studying Wnt Signaling During Patterning of Conducting Airways
Published on: October 16, 2016
Recent Development of Wnt Signaling Pathway Inhibitors for Cancer Therapeutics
Jerry Harb1, Pen-Jen Lin1, Jijun Hao2,3
1Graduate College of Biomedical Sciences, Western University of Health Sciences, Pomona, CA, 91766, USA.
Purpose Of Review:
Review current understanding of both canonical and non-canonical Wnt signaling in cancer and provide updated knowledge in current clinical trials of Wnt signaling drugs.
Recent Findings:
Important roles of both canonical and non-canonical Wnt signaling in cancer have been increasingly recognized. Recent clinical trials of several Wnt-signaling drugs have showed promising outcomes. In addition, some drugs that were originally approved for the treatment of other diseases have been recently found to block Wnt signaling, highlighting their potential to treat Wnt-dependent cancer. Dysfunction of Wnt signaling is implicated in cancer, and targeting Wnt signaling represents a useful approach to treat cancer. Current clinical trials of Wnt signaling drugs have showed promising outcomes, and repurposing the previously approved drugs for other diseases to treat Wnt-dependent cancer requires further studies.
Insights
Wnt signaling plays a key role in cancer development. Targeting Wnt signaling pathways with new and repurposed drugs shows promise in ongoing clinical trials for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Wnt signaling pathways, both canonical and non-canonical, are increasingly recognized for their critical roles in various cancers.
- Dysregulation of Wnt signaling is a common hallmark of cancer, driving tumor initiation and progression.
Purpose of the Study:
- To review the current understanding of canonical and non-canonical Wnt signaling in cancer.
- To provide updated knowledge on ongoing clinical trials involving Wnt signaling inhibitors.
Main Methods:
- Literature review of Wnt signaling in cancer.
- Analysis of recent clinical trial data for Wnt signaling drugs.
- Exploration of drug repurposing for Wnt-dependent cancers.
Main Results:
- Wnt signaling is fundamentally implicated in cancer pathogenesis.
- Recent clinical trials of Wnt signaling-targeting drugs demonstrate encouraging outcomes.
- Existing drugs approved for other conditions show potential for repurposing to block Wnt signaling in cancer.
Conclusions:
- Targeting Wnt signaling is a viable therapeutic strategy for treating cancer.
- Further research is needed to explore the efficacy of repurposed drugs in Wnt-dependent cancers.
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

